Translational Scholar Career Awards in Pharmacogenomics and Personalized Medicine (K23)

The summary for the Translational Scholar Career Awards in Pharmacogenomics and Personalized Medicine (K23) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Translational Scholar Career Awards in Pharmacogenomics and Personalized Medicine (K23): Purpose. The purpose of this Mentored Patient-Oriented Research Career Development Award (K23) is to provide salary and protected time (up to five years for this award) to support the career development of investigators who have made a commitment to focus their research endeavors on patient-oriented research. Each Research Career Development Award must be tailored to meet the individual needs of the candidate. The Translational Scholar Awards in Pharmacogenomics and Personalized Medicine program is intended to address the scarcity of investigators cross-trained in both clinical research core competencies and modern methods required to address pharmacogenomics research problems in patient populations. Dual mentors from the Clinical and Translational Science Awards consortium and the Pharmacogenomics Research Network are required. Mechanism of Support. This FOA will utilize the NIH Research Career Development Award K23 award mechanism. Funds Available and Anticipated Number of Awards. For this funding opportunity, the total amount to be awarded will be up to $1.5 M and the anticipated number of awards will be approximately six in FY2012. The total amount awarded and the number of awards will depend upon the number, quality, duration, and costs of the applications received.

Federal Grant Title:	Translational Scholar Career Awards in Pharmacogenomics and Personalized Medicine (K23)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Education Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PA-11-009
Type of Funding:	Grant
CFDA Numbers:	93.233
CFDA Descriptions:	National Center on Sleep Disorders Research
Current Application Deadline:	Jan 07, 2014
Original Application Deadline:	Jan 07, 2014
Posted Date:	Oct 14, 2010
Creation Date:	Oct 14, 2010
Archive Date:	Feb 07, 2014
Total Program Funding:	$1,500,000
Maximum Federal Grant Award:	$200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) .
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Cell and Gene Therapies for HIV Cure: Developing a Pipeline (P01 Clinical Trial Not Allowe...; • NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (...; • NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (...; • Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Researc...; • Cardiovascular Repository Type 1 Diabetes (CARE-T1D) Consortium (U01 Clinical Trial Not Al...; • Ancillary Studies in Clinical Trials (R01); • Opportunity PA-08-021; • Research Demonstration and Dissemination Grants (R18)
More Grants from the National Institutes of Health: • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional); • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...